Cerity Partners’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.68M Buy
32,005
+169
+0.5% +$6.6K ﹤0.01% 1691
2026
Q1
$1.13M Sell
31,836
-494
-2% -$15.3K ﹤0.01% 1792
2025
Q4
$905K Buy
32,330
+16,562
+105% +$496K ﹤0.01% 1760
2025
Q3
$473K Sell
15,768
-4,242
-21% -$120K ﹤0.01% 2010
2025
Q2
$572K Sell
20,010
-6,230
-24% -$185K ﹤0.01% 1798
2025
Q1
$866K Buy
26,240
+8,310
+46% +$271K ﹤0.01% 1494
2024
Q4
$511K Buy
17,930
+2,234
+14% +$64.2K ﹤0.01% 1748
2024
Q3
$439K Buy
+15,696
New +$418K ﹤0.01% 1842
2024
Q2
– Sell
-23,960
Closed -$649K – 2231
2024
Q1
$649K Buy
+23,960
New +$680K ﹤0.01% 1476

Other funds holding ALKS

Cerity Partners's ALKS Position: Q2 2026 in Review

Cerity Partners increased its Alkermes (ALKS) stake by 0.53% in Q2 2026, buying an estimated $6.6K and bringing the position to 32,005 shares worth $1.68M. The position accounts for ﹤0.01% of the portfolio, ranked #1691.

Cerity Partners first reported a position in ALKS in Q1 2024 and has held it in 9 quarters since. 424 funds tracked by Wall St. Rank hold ALKS as of Q2 2026.

  • Cerity Partners held 32,005 shares of Alkermes worth $1.68M as of Q2 2026.
  • Cerity Partners bought 169 Alkermes shares in Q2 2026, an estimated $6.6K.
  • Alkermes made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #1691 holding.
  • Cerity Partners first reported a position in Alkermes in Q1 2024 and has held it in 9 quarters since.
  • 424 funds tracked by Wall St. Rank held Alkermes as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.